Connect with us

Fitness

Prevalence of vitamin D deficiency and the effect of vitamin D3 supplementation on response to anti-tuberculosis therapy in patients with extrapulmonary tuberculosis – BMC Infectious Diseases

Published

on

Prevalence of vitamin D deficiency and the effect of vitamin D3 supplementation on response to anti-tuberculosis therapy in patients with extrapulmonary tuberculosis – BMC Infectious Diseases

  • World Health Organization. Global tuberculosis report 2022. Geneva. Switzerland: World Health Organization; 2022. https://www.who.int/teams/global-tuberculosis-programme/data.


    Google Scholar
     

  • World Health Organization. WHO, Egypt tuberculosis profile 2021. Avilable from: https://worldhealthorg.shinyapps.io/tb_profiles/?_inputs_&entity_type=%22country%22&lan=%22EN%22&iso2=%22EG%22

  • Junaid K, Rehman A. Impact of vitamin D on infectious disease-tuberculosis-a review. Clin Nutr Experimental. 2019;25:1–0.

    Article 

    Google Scholar
     

  • Sanlier N, Guney-Coskun M, Vitamin D. The immune system, and its relationship with diseases. Egypt Pediatr Association Gaz. 2022;70(1):39.

    Article 

    Google Scholar
     

  • Sutaria N, Liu CT, Chen TC. Vitamin D status, receptor gene polymorphisms, and supplementation on tuberculosis: a systematic review of case-control studies and randomized controlled trials. J Clin Translational Endocrinol. 2014;1(4):151–60.

    Article 

    Google Scholar
     

  • Zeng J, Wu G, Yang W, Gu X, Liang W, Yao Y, Song Y. A serum vitamin D level 

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Reijven PL, Soeters PB. Vitamin D: a magic bullet or a myth? Clin Nutr. 2020;39(9):2663–74.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Khammissa RA, Fourie J, Motswaledi MH, Ballyram R, Lemmer J, Feller L. The biological activities of vitamin D and its receptor in relation to calcium and bone homeostasis, cancer, immune and cardiovascular systems, skin biology, and oral health. BioMed research international. 2018;2018.

  • Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319–29.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dusso AS, Brown AJ, Slatopolsky E, Vitamin D. Am J Physiology-Renal Physiol. 2005;289.

  • Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770–3.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sly LM, Lopez M, Nauseef WM, Reiner NE. 1α, 25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem. 2001;276(38):35482–93.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Coussens A, Timms PM, Boucher BJ, Venton TR, Ashcroft AT, Skolimowska KH, Newton SM, Wilkinson KA, Davidson RN, Griffiths CJ, Wilkinson RJ. 1α, 25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology. 2009;127(4):539–48.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gombart AF. The vitamin D–antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 2009;4(9):1151–65.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • McCullough PJ, Lehrer DS, Vitamin D. Cod liver oil, sunshine, and phototherapy: safe, effective and forgotten tools for treating and curing tuberculosis infections—A comprehensive review. J Steroid Biochem Mol Biol. 2018;177:21–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Dowling GB, Prosser Thomas EW. Lupus vulgaris treated with calciferol. Proc R Soc Med. 1945;39:96–9.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dowling GB, Prosser Thomas EW, Wallace HJ. Lupus Vulgaris treated with Calciferol. Proc R Soc Med. 1946;39(5):225–7.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Michelson HE, Steves RJ. Treatment of cutaneous tuberculosis with large doses of vitamin D2. Archives Dermatology Syphilology. 1947;56(3):317–24.

    Article 
    CAS 

    Google Scholar
     

  • Tomlinson KM. Calcium content of skin in lupus vulgaris treated with calciferol. Lancet. 1948;254:327–8.

    Article 
    CAS 

    Google Scholar
     

  • Hassanein EG, Mohamed EE, Baess AI, El-Sayed ET, Yossef AM. The role of supplementary vitamin D in treatment course of pulmonary tuberculosis. Egypt J Chest Dis Tuberculosis. 2016;65(3):629–35.

    Article 

    Google Scholar
     

  • Sato S, Tanino Y, Saito J, Nikaido T, Inokoshi Y, Fukuhara A, Fukuhara N, Wang X, Ishida T, Munakata M. The relationship between 25-hydroxyvitamin D levels and treatment course of pulmonary tuberculosis. Respiratory Invest. 2012;50(2):40–5.

    Article 

    Google Scholar
     

  • Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Hemoglobin. 2006;1500:1500.


    Google Scholar
     

  • Kota SK, Jammula S, Kota SK, Tripathy PR, Panda S, Modi KD. Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes Metabolic Syndrome: Clin Res Reviews. 2011;5(2):85–9.

    Article 

    Google Scholar
     

  • Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT study [Supplementary cholecalciferol in recovery from Tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’. BMC Infect Dis. 2013;13(1):1–11.

    Article 

    Google Scholar
     

  • Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC, Darmalingam M, Davidson RN, Milburn HJ. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011;377(9761):242–50.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, Darmalingam M. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proceedings of the National Academy of Sciences. 2012;109(38):15449-54.

  • Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, Andersen PL, Glerup H, Sodemann M. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2009;179(9):843–50.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ganmaa D, Munkhzul B, Fawzi W, Spiegelman D, Willett WC, Bayasgalan P, Baasansuren E, Buyankhishig B, Oyun-Erdene S, Jolliffe DA, Xenakis T. High-dose vitamin D3 during tuberculosis treatment in Mongolia. A randomized controlled trial. Am J Respir Crit Care Med. 2017;196(5):628–37.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • World Health Organization. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: recommendations for HIV-prevalent and resource-constrained settings. World Health Organization; 2007.

  • WHO. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis—rapid diagnostics for tuberculosis detection, 2021 update.

  • Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J. 1973;4(5893):643–6.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Giustina A, Adler RA, Binkley N, Bouillon R, Ebeling PR, Lazaretti-Castro M, Marcocci C, Rizzoli R, Sempos CT, Bilezikian JP. Controversies in vitamin D: summary statement from an international conference. The Journal of Clinical Endocrinology & Metabolism. 2019;104(2):234 – 40.

  • Francis RM, Aspray TJ, Bowring CE, Fraser WD, Gittoes NJ, Javaid MK, Macdonald HM, Patel S, Selby PL, Tanna N. National Osteoporosis Society practical clinical guideline on vitamin D and bone health. Maturitas. 2015;80(2):119–21.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hammami F, Koubaa M, Mejdoub Y, Turki M, Ayed HB, Chakroun A, Rekik K, Smaoui F, Jemaa MB. The association between vitamin D deficiency and extrapulmonary tuberculosis: case-control study. Tuberculosis. 2021;126:102034.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Balgi V, Sanjana JM, Suneetha DK, Surendran A, Chandrashekar GS. The study of correlation between vitamin D and tuberculosis in newly detected tuberculosis-pulmonary and extra pulmonary patients attending to KR hospital, Mysuru, Karnataka, India. Int J Adv Med. 2020;7(1):34.

    Article 

    Google Scholar
     

  • Pareek M, Innes J, Sridhar S, Grass L, Connell D, Woltmann G, Wiselka M, Martineau AR, Kon OM, Dedicoat M, Lalvani A. Vitamin D deficiency and TB disease phenotype. Thorax. 2015;70(12):1171–80.

    Article 
    PubMed 

    Google Scholar
     

  • Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, Chugh S, Deshpande S, Ford C, Gama R. Vitamin D: a negative acute phase reactant. J Clin Pathol. 2013;66(7):620–2.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Conesa-Botella A, Meintjes G, Coussens AK, van der Plas H, Goliath R, Schutz C, Moreno-Reyes R, Mehta M, Martineau AR, Wilkinson RJ, Colebunders R. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Clin Infect Dis. 2012;55(7):1004–11.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Antonelli MJ, Kushner I, Epstein M. The constellation of vitamin D, the acute-phase response, and inflammation. Cleve Clin J Med. 2023;90(2):85–9.

    Article 
    PubMed 

    Google Scholar
     

  • Matos ED, Moreira Lemos AC. Association between serum albumin levels and in-hospital deaths due to tuberculosis. Int J Tuberc Lung Dis. 2006;10(12):1360–6.

    CAS 
    PubMed 

    Google Scholar
     

  • Gil-Santana L, Cruz LA, Arriaga MB, Miranda PF, Fukutani KF, Silveira-Mattos PS, Silva EC, Oliveira MG, Mesquita ED, Rauwerdink A, Cobelens F. Tuberculosis-associated anemia is linked to a distinct inflammatory profile that persists after initiation of antitubercular therapy. Sci Rep. 2019;9(1):1381.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bernabe-Ortiz A, Carcamo CP, Sanchez JF, Rios J. Weight variation over time and its association with tuberculosis treatment outcome: a longitudinal analysis. PLoS ONE. 2011;6(4):e18474.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hoa NB, Lauritsen JM, Rieder HL. Changes in body weight and tuberculosis treatment outcome in Viet Nam. Int J Tuberc Lung Dis. 2013;17(1):61–6.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jørstad MD, Dyrhol-Riise AM, Aßmus J, Marijani M, Sviland L, Mustafa T. Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting. BMC Infect Dis. 2019;19(1):1–9.

    Article 

    Google Scholar
     

  • Khan A, Sterling TR, Reves R, Vernon A, Horsburgh CR, Tuberculosis Trials Consortium. Lack of weight gain and relapse risk in a large tuberculosis treatment trial. Am J Respir Crit Care Med. 2006;174(3):344–8.

    Article 
    PubMed 

    Google Scholar
     

  • Daley P, Jagannathan V, John KR, Sarojini J, Latha A, Vieth R, Suzana S, Jeyaseelan L, Christopher DJ, Smieja M, Mathai D. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015;15(5):528–34.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Mily A, Rekha RS, Kamal SM, Arifuzzaman AS, Rahim Z, Khan L, Haq MA, Zaman K, Bergman P, Brighenti S, Gudmundsson GH. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS ONE. 2015;10(9):e0138340.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Araki T, Holick MF, Alfonso BD, Charlap E, Romero CM, Rizk D, Newman LG. Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States. J Clin Endocrinol Metabolism. 2011;96(12):3603–8.

    Article 
    CAS 

    Google Scholar
     

  • McCullough PJ, Lehrer DS, Amend J. Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: insights from a seven year experience. J Steroid Biochem Mol Biol. 2019;189:228–39.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Continue Reading